Company profile: Genzyme
1.1 - Company Overview
Company description
- Provider of biotechnology products and services focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease, operating across four segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery, and Hematologic Oncology.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genzyme
Meda Pharma
HQ: United States
Website
- Description: Provider of pharmaceutical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meda Pharma company profile →
Rexahn Pharmaceuticals
HQ: United States
Website
- Description: Provider of treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rexahn Pharmaceuticals company profile →
Medarex
HQ: United States
Website
- Description: Provider of fully human antibody-based therapeutics, focused on discovering, developing and commercializing treatments for life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases, leveraging its UltiMAb technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medarex company profile →
SurfaceLogix
HQ: United States
Website
- Description: Provider of drug development leveraging biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic and pharmacodynamic properties compared with class leaders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SurfaceLogix company profile →
Herantis Pharma
HQ: Finland
Website
- Description: Provider of pharmaceutical therapies targeting unmet clinical needs, including HER-096, a small synthetic peptidomimetic based on the CDNF protein's active site for treating Parkinson’s disease, designed for subcutaneous administration and demonstrating good safety, tolerability, and efficient blood-brain barrier penetration in Phase 1a clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Herantis Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genzyme
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genzyme
2.2 - Growth funds investing in similar companies to Genzyme
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genzyme
4.2 - Public trading comparable groups for Genzyme
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →